Thromboxane synthase immunohistochemistry in inflammatory bowel disease

Area of Science:

• Gastroenterology
• Immunohistochemistry
• Molecular Biology

Background:

• Thromboxanes are overproduced in inflammatory bowel disease (IBD).
• Preliminary studies indicate thromboxane synthase inhibitors may benefit ulcerative colitis patients.

Purpose of the Study:

• To investigate the immunohistochemical expression of thromboxane synthase in the colorectal mucosa of IBD patients.
• To correlate thromboxane synthase expression with disease activity.

Main Methods:

• Immunostaining of colonic biopsies from IBD patients (n=13) and controls (n=5) using a monoclonal antibody to human thromboxane synthase.
• Comparison of staining extent in lamina propria cells between groups.
• Assessment of staining in relation to macroscopic and histologic disease activity.

Main Results:

• Higher percentage of lamina propria cells stained for thromboxane synthase in active IBD patients compared to inactive IBD or controls.
• Direct correlation between disease activity (endoscopic and histologic) and thromboxane synthase-positive cells (R=0.71-0.72, p=0.001).

Conclusions:

• Increased thromboxane synthase expression in lamina propria cells is associated with active IBD.
• This upregulation may lead to increased thromboxane synthesis, contributing to mucosal inflammation and intramucosal thrombosis.